SMS Pharmaceuticals Profit & Loss Annual

Trade
BSE: 532815 | NSE: SMSPHARMA | ISIN: INE812G01025 | Sector: Biotechnology & Drugs
204.05 +2.95 (1.47%)Updated : 24 May 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 522.05519.87563.18411.95
Total Revenue 522.05519.87563.18411.95
Costof Revenue Total 379.78315.99370.05272.03
Gross Profit 142.27203.88193.12139.92
Selling/ General/ Admin Expenses Total 87.6989.5572.0059.95
Depreciation/ Amortization 32.1332.1522.2822.07
Total Operating Expense 499.60437.69464.34354.04
Operating Income 22.4582.1898.8457.91
Interest Inc( Exp) Net- Non- Op Total -162.82-147.29-93.43-89.41
Gain( Loss)on Saleof Assets -0.72-0.04-0.08-0.51
Other Net -0.751.051.631.84
Net Income Before Taxes 5.3568.5091.1250.76
Provisionfor Income Taxes 1.470.6230.1618.07
Net Income After Taxes 3.8867.8860.9632.69
Equity In Affiliates -109.43-56.6115.62-11.15
Net Income Before Extra Items -7.0662.2262.5331.57
Net Income -7.0662.2262.5331.57
Income Availableto Com Excl Extra Ord -7.0662.2262.5331.57
Income Availableto Com Incl Extra Ord -7.0662.2262.5331.57
Diluted Net Income -7.0662.2262.5331.57
Diluted Weighted Average Shares 8.478.478.478.47
Diluted EPS Excluding Extra Ord Items -0.837.357.393.73
DPS- Common Stock Primary Issue 0.300.300.300.25
Diluted Normalized EPS -0.837.357.393.73
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,516.65+24.45(1.64%)
1,389.40+15.45(1.12%)
3,625.95+39.80(1.11%)
2,867.40-35.05 (-1.21%)
1,321.90-15.80 (-1.18%)
HomeMarketsPremiumFor youGet App